JPMorgan initiates Odyssey Therapeutics stock rating at Overweight - Stock Watch Index

JPMorgan initiates Odyssey Therapeutics stock rating at Overweight

June 1, 2026

JPMorgan initiates Odyssey Therapeutics stock rating at Overweight

Search

RECENT PRESS RELEASES

Bitcoin’s biggest ETF selloff yet hits $3.4 billion as AI stocks keep climbing

SWI Editorial Staff2026-06-01T23:47:47-07:00June 1, 2026|

Bitcoin slides to $70k on Strategy sale, Iran uncertainty

SWI Editorial Staff2026-06-01T23:43:01-07:00June 1, 2026|

Ethtry Purchases 108.33 Ethereum As Part Of Treasury Strategy

SWI Editorial Staff2026-06-01T23:33:33-07:00June 1, 2026|

Valeo Presents its Latest Ineez AC Charging Station at Drive to Zero 2026

SWI Editorial Staff2026-06-01T23:30:09-07:00June 1, 2026|

Clean hydrogen can plug the gaps in a decarbonised energy system

SWI Editorial Staff2026-06-01T23:19:58-07:00June 1, 2026|

The Market Overreacted to the DEA’s Marijuana Rescheduling — Here’s What It Means for Canopy Growth Stock Now

SWI Editorial Staff2026-06-01T23:12:40-07:00June 1, 2026|

Related Post